We have located links that may give you full text access.
Visceral fat does not contribute to metabolic disease in lipodystrophy.
Obesity Science & Practice 2019 Februrary
Objectives: Lipodystrophies are characterized by regional or generalized loss of adipose tissue and severe metabolic complications. The role of visceral adipose tissue (VAT) in the development of metabolic derangements in lipodystrophy is unknown. The study aim was to investigate VAT contribution to metabolic disease in lipodystrophy versus healthy controls.
Methods: Analysis of correlations between VAT volume and biomarkers of metabolic disease in 93 patients and 93 age/sex-matched healthy controls.
Results: Patients with generalized lipodystrophy ( n = 43) had lower VAT compared with matched controls, while those with partial lipodystrophy ( n = 50) had higher VAT versus controls. Both groups with lipodystrophy had lower leg fat mass versus controls ( p < 0.05 for all; unpaired t -test). In both generalized and partial lipodystrophy, there was no correlation between VAT and glucose, triglycerides or high-density lipoprotein cholesterol ( p > 0.05 for all; Spearman correlation). In controls matched to patients with generalized or partial lipodystrophy, VAT correlated with glucose ( R = 0.42 and 0.36), triglycerides ( R = 0.36 and 0.60) and high-density lipoprotein cholesterol ( R = -0.34 and -0.64) ( p < 0.05 for all; Spearman correlation).
Conclusions: In contrast to healthy controls, metabolic derangements in lipodystrophy did not correlate with VAT volume. These data suggest that, in lipodystrophy, impaired peripheral subcutaneous fat deposition may exert a larger effect than VAT accumulation on the development of metabolic complications. Interventions aimed at increasing functional subcutaneous adipose tissue may provide metabolic benefit.
Methods: Analysis of correlations between VAT volume and biomarkers of metabolic disease in 93 patients and 93 age/sex-matched healthy controls.
Results: Patients with generalized lipodystrophy ( n = 43) had lower VAT compared with matched controls, while those with partial lipodystrophy ( n = 50) had higher VAT versus controls. Both groups with lipodystrophy had lower leg fat mass versus controls ( p < 0.05 for all; unpaired t -test). In both generalized and partial lipodystrophy, there was no correlation between VAT and glucose, triglycerides or high-density lipoprotein cholesterol ( p > 0.05 for all; Spearman correlation). In controls matched to patients with generalized or partial lipodystrophy, VAT correlated with glucose ( R = 0.42 and 0.36), triglycerides ( R = 0.36 and 0.60) and high-density lipoprotein cholesterol ( R = -0.34 and -0.64) ( p < 0.05 for all; Spearman correlation).
Conclusions: In contrast to healthy controls, metabolic derangements in lipodystrophy did not correlate with VAT volume. These data suggest that, in lipodystrophy, impaired peripheral subcutaneous fat deposition may exert a larger effect than VAT accumulation on the development of metabolic complications. Interventions aimed at increasing functional subcutaneous adipose tissue may provide metabolic benefit.
Full text links
Trending Papers
A Personalized Approach to the Management of Congestion in Acute Heart Failure.Heart International 2023
Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium-Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart Failure.International Journal of Molecular Sciences 2024 Februrary 21
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app